Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 67, Issue 2
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Pancreas
Original article
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Free
Online download statistics by month:
Online download statistics by month: October 2016 to March 2024
Abstract
Full
Pdf
Oct 2016
627
29
63
Nov 2016
558
347
338
Dec 2016
331
132
141
Jan 2017
221
147
141
Feb 2017
231
114
84
Mar 2017
158
147
94
Apr 2017
131
101
55
May 2017
88
115
73
Jun 2017
128
62
37
Jul 2017
198
64
40
Aug 2017
216
65
48
Sep 2017
165
74
49
Oct 2017
340
61
49
Nov 2017
223
63
52
Dec 2017
265
61
46
Jan 2018
3922
194
112
Feb 2018
623
147
87
Mar 2018
631
145
86
Apr 2018
527
117
55
May 2018
564
102
83
Jun 2018
431
107
77
Jul 2018
426
110
66
Aug 2018
439
89
65
Sep 2018
381
81
57
Oct 2018
430
86
53
Nov 2018
450
104
59
Dec 2018
439
119
77
Jan 2019
474
138
80
Feb 2019
370
52
43
Mar 2019
406
74
76
Apr 2019
312
66
35
May 2019
210
252
100
Jun 2019
181
221
82
Jul 2019
249
242
100
Aug 2019
347
337
100
Sep 2019
219
221
89
Oct 2019
197
207
73
Nov 2019
203
215
73
Dec 2019
189
192
78
Jan 2020
205
177
78
Feb 2020
143
126
80
Mar 2020
165
145
106
Apr 2020
152
137
101
May 2020
190
163
161
Jun 2020
182
135
107
Jul 2020
242
185
100
Aug 2020
144
100
120
Sep 2020
216
136
107
Oct 2020
234
183
102
Nov 2020
192
141
103
Dec 2020
200
158
93
Jan 2021
461
153
123
Feb 2021
201
153
117
Mar 2021
223
152
104
Apr 2021
164
128
85
May 2021
210
165
117
Jun 2021
147
147
102
Jul 2021
133
132
92
Aug 2021
143
142
108
Sep 2021
162
158
102
Oct 2021
237
189
163
Nov 2021
262
177
134
Dec 2021
213
189
109
Jan 2022
208
161
104
Feb 2022
209
142
131
Mar 2022
256
201
116
Apr 2022
312
269
139
May 2022
265
212
155
Jun 2022
214
163
147
Jul 2022
270
200
108
Aug 2022
221
153
88
Sep 2022
235
170
104
Oct 2022
289
221
130
Nov 2022
253
185
121
Dec 2022
267
179
91
Jan 2023
266
189
94
Feb 2023
256
171
96
Mar 2023
296
221
127
Apr 2023
238
143
98
May 2023
223
146
80
Jun 2023
221
129
80
Jul 2023
192
129
69
Aug 2023
269
168
99
Sep 2023
268
166
88
Oct 2023
307
245
78
Nov 2023
449
360
103
Dec 2023
338
196
105
Jan 2024
352
167
84
Feb 2024
263
172
120
Mar 2024
273
182
211
Total
28531
13911
8696
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?